Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla)

Journal of Comparative Neurology

Volumn 521, Issue 18, 2013, Pages 4318-4338

  Perez, Sylvia E ^a   Raghanti, Mary Ann ^b,c   Hof, Patrick R ^d   Kramer, Lynn ^e   Ikonomovic, Milos D ^f,g   Lacor, Pascale N ^h   Erwin, Joseph M ⁱ   Sherwood, Chet C ⁱ   Mufson, Elliott J ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b KENT STATE UNIVERSITY   (United States)

^c CLEVELAND METROPARKS ZOO   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e Dallas Zoological Society   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Aging; Amyloid; Brain; Evolution; Great ape; Mammals; Pathology; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CHOLINE ACETYLTRANSFERASE;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN BLOOD VESSEL; BRAIN MAPPING; BRAIN TISSUE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GORILLA; HIPPOCAMPUS; HISTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; WESTERN LOWLAND GORILLA;

AGING; AMYLOID; BRAIN; EVOLUTION; GREAT APE; MAMMALS; PATHOLOGY; TAU;

ALZHEIMER DISEASE; ANIMALS; FEMALE; GORILLA GORILLA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID; TAU PROTEINS;

EID: 84886646774     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23428     Document Type: Article

References (117)

1. Adroer R, López-Acedo C, Oliva R. 1997. Conserved elements in the 5' regulatory region of the amyloid precursor protein gene in primates. Neurosci Lett 226:203-206.
2. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639.
3. Atsalis S, Margulis S. 2008. Primate reproductive aging: from lemurs to humans. Interdiscipl Top Gerontol 36:186-194.
4. Attems J, Lintner F, Jellinger KA. 2004. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107:283-291.
5. Attems J, Jellinger KA, Lintner F. 2005. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol 110:222-231.
6. Benzing WC, Kordower JH, Mufson EJ. 1993. Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J Comp Neurol 336:31-39.
7. Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP. 1995. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 52:81-88.
8. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW. 2005. Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 1739:216-223.
9. Bons N, Rieger F, Prudhomme D, Fisher A, Krause KH. 2006. Microcebus murinus: a useful primate model for human cerebral aging and Alzheimer's disease? Genes Brain Behav 5:120-130.
10. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH. 1994. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb Cortex 4:138-150.
11. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
12. Brellou G, Vlemmas I, Lekkas S, Papaioannou N. 2005. Immunohistochemical investigation of amyloid beta-protein (Aβ) in the brain of aged cats. Histol Histopathol 20:725-731.
13. Brion JP. 1998. Neurofibrillary tangles and Alzheimer's disease. Eur Neurol 40:130-140.
14. Brodmann K. 1909. Vergleichende Lokalisationslehre der Grosshirnrinde. Leipzig: Johann Ambrosius Barth.
15. Bronikowski AM, Altmann J, Brockman DK, Cords M, Fedigan LM, Pusey A, Stoinski T, Morris WF, Strier KB, Alberts SC. 2011. Aging in the natural world: comparative data reveal similar mortality patterns across primates. Science 331:1325-1328.
16. Carmel G, Mager EM, Binder LI, Kuret J. 1996. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 271:32789-32795.
17. Clifford PM, Siu G, Kosciuk M, Levin EC, Venkataraman V, D'Andrea MR, Nagele RG. 2008. Alpha7 nicotinic acetylcholine receptor expression by vascular smooth muscle cells facilitates the deposition of Aβ peptides and promotes cerebrovascular amyloid angiopathy. Brain Res 1234:158-171.
18. Cork LC. 1993. Plaques in prefrontal cortex of aged, behaviorally-tested rhesus monkeys: incidence, distribution, and relationship to task performance. Neurobiol Aging 14:675-676.
19. Cork LC, Powers RE, Selkoe DJ, Davies P, Geyer JJ, Price DL. 1988. Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol 47:629-641.
20. De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL. 2008. Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 29:1334-1347.
21. Di Patre PL. 1991. Cytoskeletal alterations might account for the phylogenetic vulnerability of the human brain to Alzheimer's disease. Med Hypotheses 34:165-170.
22. Doran DM, McNeilage A, Greer D, Bocian C, Mehlman P, Shah N. 2002. Western lowland gorilla diet and resource availability: new evidence, cross-site comparisons, and reflections on indirect sampling methods. Am J Primatol 58:91-116.
23. Elfenbein HA, Rosen RF, Stephens SL, Switzer RC, Smith Y, Pare J, Mehta PD, Warzok R, Walker LC. 2007. Cerebral beta-amyloid angiopathy in aged squirrel monkeys. Histol Histopathol 22:155-167.
24. Gaillard F, Bonfield S, Gilmour GS, Kuny S, Mema SC, Martin BT, Smale L, Crowder N, Stell WK, Sauvé Y. 2008. Retinal anatomy and visual performance in a diurnal cone-rich laboratory rodent, the Nile grass rat (Arvicanthis niloticus). J Comp Neurol 510:525-538.
25. García-Sierra F, Ghoshal N, Quinn B, Berry RW, Binder LI. 2003. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimer Dis 5:65-77.
26. Gearing M, Tigges J, Mori H, Mirra SS. 1996. Aβ40 is a major form of beta-amyloid in nonhuman primates. Neurobiol Aging 17:903-908.
27. Gearing M, Tigges J, Mori H, Mirra SS. 1997. β-Amyloid (Aβ) deposition in the brains of aged orangutans. Neurobiol Aging 18:139-146.
28. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA. 1998. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4:827-831.
29. Geula C, Nagykery N, Wu CK. 2002. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol 103:48-58.
30. Giannakopoulos P, Herrmann FR, Bussiere T, Bouras C, Kovari E, Perl DP, Morrison JH, Gold G, Hof PR. 2003. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60:1495-1500.
31. Ginsberg SD, Che S, Counts SE, Mufson EJ. 2006. Shift in the ratio of three-repeat tau and four-repeat tau mRNAs in individual cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Neurochem 96:1401-1408.
32. Goedert M, Jakes R, Spillantini MG, Crowther RA, Cohen P, Vanmechelen E, Probst A, Gotz J, Burki K. 1995a. Tau protein in Alzheimer's disease. Biochem Soc Trans 23:80-85.
33. Goedert M, Jakes R, Vanmechelen E. 1995b. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189:167-169.
34. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. 1996. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16:4491-4500.
35. Haase C, Stieler JT, Arendt T, Holzer M. 2004. Pseudophosphorylation of tau protein alters its ability for self-aggregation. J Neurochem 88:1509-1520.
36. Hartig W, Klein C, Brauer K, Schuppel KF, Arendt T, Bruckner G, Bigl V. 2000. Abnormally phosphorylated protein tau in the cortex of aged individuals of various mammalian orders. Acta Neuropathol 100:305-312.
37. Hill J, Inder T, Neil J, Dierker D, Harwell J, Van Essen D. 2010. Similar patterns of cortical expansion during human development and evolution. Proc Natl Acad Sci U S A 107:13135-13140.
38. Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, Niikura T, Hua F, Tsukagoshi-Nagai H, Horikoshi-Sakuraba Y, Mughal M, Rebeck GW, LaFerla FM, Mattson MP, Iwata N, Saido TC, Klein WL, Duff KE, Aisen PS, Matsuoka Y. 2008. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res 1216:92-103.
39. Holzer M, Craxton M, Jakes R, Arendt T, Goedert M. 2004. Tau gene (MAPT) sequence variation among primates. Gene 341:313-322.
40. Huxley TH. 1863. Evidence as to Man's place in Nature. London: Williams and Norgate.
41. Ikeda K, Akiyama H, Arai T, Nishimura T. 1998a. Glial tau pathology in neurodegenerative diseases: their nature and comparison with neuronal tangles. Neurobiol Aging 19:S85-S91.
42. Ikeda T, Homma Y, Nisida K, Hirase K, Sotozono C, Kinoshita S, Puro DG. 1998b. Expression of transforming growth factor-beta s and their receptors by human retinal glial cells. Curr Eye Res 17:546-550.
43. Ikonomovic MD, Abrahamson EE, Isanski BA, Debnath ML, Mathis CA, Dekosky ST, Klunk WE. 2006. X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease. Methods Enzymol 412:123-144.
44. Jicha GA, Bowser R, Kazam IG, Davies P. 1997. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128-132.
45. Jicha GA, Berenfeld B, Davies P. 1999. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. J Neurosci Res 55:713-723.
46. Kao PF, Davis DA, Banigan MG, Vanderburg CR, Seshadri S, Delalle I. 2010. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease. PLoS One 5:e13337.
47. Kiatipattanasakul W, Nakayama H, Yongsiri S, Chotiapisitkul S, Nakamura S, Kojima H, Doi K. 2000. Abnormal neuronal and glial argyrophilic fibrillary structures in the brain of an aged albino cynomolgus monkey (Macaca fascicularis). Acta Neuropathol 100:580-586.
48. Kim KS, Miller DL, Sapienza VJ, Chen CMJ, Bai C, Grundke-Iqbal I, Currie JR, Wisniewski HM. 1988. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid pepetide. Neurosci Res Commun 2:121-130.
49. Kimura N, Nakamura S, Goto N, Narushima E, Hara I, Shichiri S, Saitou K, Nose M, Hayashi T, Kawamura S, Yoshikawa Y. 2001. Senile plaques in an aged western lowland gorilla. Exp Anim 50:77-81.
50. Kimura N, Tanemura K, Nakamura S, Takashima A, Ono F, Sakakibara I, Ishii Y, Kyuwa S, Yoshikawa Y. 2003. Age-related changes of Alzheimer's disease-associated proteins in cynomolgus monkey brains. Biochem Biophys Res Commun 310:303-311.
51. Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, Hyman BT. 1999. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci U S A 96:5274-5279.
52. Krubitzer L. 2007. The magnificent compromise: cortical field evolution in mammals. Neuron 56:201-208.
53. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. 2004. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24:10191-10200.
54. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL. 2007. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
55. Lambert MP, Velasco PT, Chang L, Viola KL, Fernandez S, Lacor PN, Khuon D, Gong Y, Bigio EH, Shaw P, De Felice FG, Krafft GA, Klein WL. 2007. Monoclonal antibodies that target pathological assemblies of Abeta. J Neurochem 100:23-35.
56. Langergraber KE, Prüfer K, Rowney C, Boesch C, Crockford C, Fawcett K, Inoue E, Inoue-Muruyama M, Mitani JC, Muller MN, Robbins MM, Schubert G, Stoinski TS, Viola B, Watts D, Wittig RM, Wrangham RW, Zuberbühler K, Pääbo S, Vigilant L. 2012. Generation times in wild chimpanzees and gorillas suggest earlier divergence times in great ape and human evolution. Proc Natl Acad Sci U S A 109:15716-15721.
57. Lemere CA, Beierschmitt A, Iglesias M, Spooner ET, Bloom JK, Leverone JF, Zheng JB, Seabrook TJ, Louard D, Li D, Selkoe DJ, Palmour RM, Ervin FR. 2004. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet. Am J Pathol 165:283-297.
58. Lemere CA, Jiwon Oh, Heather A. Stantish, Ying Peng, Imelda Pepivani, Anne M. Fagan, Haruyasu Yamaguchi, Susan V. Westmoreland, Keith G. Mansfield. 2008. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease? Rejuven Res 11:321-332.
59. Li F, Iseki E, Kosaka K, Nishimura T, Akiyama H, Kato M. 1996. Progressive supranuclear palsy with fronto-temporal atrophy and various tau-positive abnormal structures. Clin Neuropathol 15:319-323.
60. Lombardo JA, Stern EA, McLellan ME, Kajdasz ST, Hickey GA, Bacskai BJ, Hyman BT. 2003. Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. J Neurosci 23:10879-10883.
61. Mantini D, Corbetta M, Romani GL, Orban GA, Vanduffel W. 2013. Evolutionarily novel functional networks in the human brain? J Neurosci 33:3259-3275.
62. Martin LJ, Sisodia SS, Koo EH, Cork LC, Dellovade TL, Weidemann A, Beyreuther K, Masters C, Price DL. 1991. Amyloid precursor protein in aged nonhuman primates. Proc Natl Acad Sci U S A 88:1461-1465.
63. Masliah E, Terry RD, Mallory M, Alford M, Hansen LA. 1990. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease. Am J Pathol 137:1293-1297.
64. Merrill DA, Masliah E, Roberts JA, McKay H, Kordower JH, Mufson EJ, Tuszynski MH. 2011. Association of early experience with neurodegeneration in aged primates. Neurobiol Aging 32:151-156.
65. Mizutani T, Inose T, Nakajima S, Kakimi S, Uchigata M, Ikeda K, Gambetti P, Takasu T. 1998. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies. Acta Neuropathol 95:15-27.
66. Morrison JH, Hof PR. 1997. Life and death of neurons in the aging brain. Science 278:412-419.
67. Mufson EJ, Bothwell M, Hersh LB, Kordower JH. 1989. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol 285:196-217.
68. Mufson EJ, Benzing WC, Cole GM, Wang H, Emerich DF, Sladek JR Jr, Morrison JH, Kordower JH. 1994. Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: colocalization with amyloid plaques. Neurobiol Aging 15:621-627.
69. Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. 1997. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 146:91-103.
70. Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. 1999. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol 158:469-490.
71. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD. 1995. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 6:21-31.
72. Nakamura S, Nakayama H, Uetsuka K, Sasaki N, Uchida K, Goto N. 1995. Senile plaques in an aged two-humped (Bactrian) camel (Camelus bactrianus). Acta Neuropathol 90:415-418.
73. Nelson PT, Greenberg SG, Saper CB. 1994. Neurofibrillary tangles in the cerebral cortex of sheep. Neurosci Lett 170:187-190.
74. Nelson PT, Stefansson K, Gulcher J, Saper CB. 1996. Molecular evolution of tau protein: implications for Alzheimer's disease. J Neurochem 67:1622-1632.
75. Olichney JM, Ellis RJ, Katzman R, Sabbagh MN, Hansen L. 1997. Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease. Ann N Y Acad Sci 826:493-497.
76. Overk CR, Lu PY, Wang YT, Choi J, Shaw JW, Thatcher GR, Mufson EJ. 2012. Effects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic mice. Neurobiol Dis 45:479-487.
77. Oyanagi K, Tsuchiya K, Yamazaki M, Ikeda K. 2001. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features. J Neuropathol Exp Neurol 60:393-402.
78. Pantelakis S. 1954. [A particular type of senile angiopathy of the central nervous system: congophilic angiopathy, topography and frequency.] Monatsschr Psychiatr Neurol 128:219-256.
79. Perez S, Sendera TJ, Kordower JH, Mufson EJ. 2004. Estrogen receptor alpha containing neurons in the monkey forebrain: lack of association with calcium binding proteins and choline acetyltransferase. Brain Res 1019:55-63.
80. Perez SE, He B, Muhammad N, Oh KJ, Fahnestock M, Ikonomovic MD, Mufson EJ. 2011. Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice. Neurobiol Dis 41:338-352.
81. Perez SE, Getova DP, He B, Counts SE, Geula C, Desire L, Coutadeur S, Peillon H, Ginsberg SD, Mufson EJ. 2012a. Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease. Am J Pathol 180:526-540.
82. Perez SE, Nadeem M, Sadleir KR, Matras J, Kelley CM, Counts SE, Vassar R, Mufson EJ. 2012b. Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice. Int J Physiol Pathophysiol Pharmacol 4:115-127.
83. Poduri A, Gearing M, Rebeck GW, Mirra SS, Tigges J, Hyman BT. 1994. Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Pathol 144:1183-1187.
84. Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC. 2009. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30:1026-1036.
85. Raghanti MA, Stimpson CD, Marcinkiewicz JL, Erwin JM, Hof PR, Sherwood CC. 2008. Cholinergic innervation of the frontal cortex: differences among humans, chimpanzees, and macaque monkeys. J Comp Neurol 506:409-424.
86. Rapoport SI. 1990. Integrated phylogeny of the primate brain, with special reference to humans and their diseases. Brain Res Rev 15:267-294.
87. Rapoport SI. 1999. Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation. Ann N Y Acad Sci 893:138-153.
88. Rapoport SI, Nelson PT. 2011. Biomarkers and evolution in Alzheimer disease. Prog Neurobiol. 95:510-513.
89. Rensink AA, de Waal RM, Kremer B, Verbeek MM. 2003. Pathogenesis of cerebral amyloid angiopathy. Brain Res Rev 43:207-223.
90. Roertgen KE, Parisi JE, Clark HB, Barnes DL, O'Brien TD, Johnson KH. 1996. A beta-associated cerebral angiopathy and senile plaques with neurofibrillary tangles and cerebral hemorrhage in an aged wolverine (Gulo gulo). Neurobiol Aging 17:243-247.
91. Rosen RF, Farberg AS, Gearing M, Dooyema J, Long PM, Anderson DC, Davis-Turak J, Coppola G, Geschwind DH, Pare JF, Duong TQ, Hopkins WD, Preuss TM, Walker LC. 2008. Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol 509:259-270.
92. Rosen RF, Walker LC, Levine H 3rd. 2011. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging 32:223-234.
93. Rosene DL, Van Hoesen GW. 1987. The hippocampal formation of the primate brain: a review of some comparative aspects of cytoarchitecture and connections. In: Jones EG, Peters A, editors. Cerebral cortex. Further aspects of cortical function, including hippocampus. New York: Plenum Press, p 345-456.
94. Scally A, Dutheil JY, Hillier LW, Jordan GE, Goodhead I, Herrero J, Hobolth A, Lappalainen T, Mailund T, Marques-Bonet T, McCarthy S, Montgomery SH, Schwalie PC, Tang YA, Ward MC, Xue Y, Yngvadottir B, Alkan C, Andersen LN, Ayub Q, Ball EV, Beal K, Bradley BJ, Chen Y, Clee CM, Fitzgerald S, Graves TA, Gu Y, Heath P, Heger A, Karakoc E, Kolb-Kokocinski A, Laird GK, Lunter G, Meader S, Mort M, Mullikin JC, Munch K, O'Connor TD, Phillips AD, Prado-Martinez J, Rogers AS, Sajjadian S, Schmidt D, Shaw K, Simpson JT, Stenson PD, Turner DJ, Vigilant L, Vilella AJ, Whitener W, Zhu B, Cooper DN, de Jong P, Dermitzakis ET, Eichler EE, Flicek P, Goldman N, Mundy NI, Ning Z, Odom DT, Ponting CP, Quail MA, Ryder OA, Searle SM, Warren WC, Wilson RK, Schierup MH, Rogers J, Tyler-Smith C, Durbin R. 2012. Insights into hominid evolution from the gorilla genome sequence. Nature 483:169-175.
95. Schultz C, Dehghani F, Hubbard GB, Thal DR, Struckhoff G, Braak E, Braak H. 2000. Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons. J Neuropathol Exp Neurol 59:39-52.
96. Selkoe DJ. 2000. The origins of Alzheimer disease: A is for amyloid. JAMA 283:1615-1617.
97. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
98. Semendeferi K, Teffer K, Buxhoeveden DP, Park MS, Bludau S, Amunts K, Travis K, Buckwalter J. 2011. Spatial organization of neurons in the frontal pole sets humans apart from great apes. Cereb Cortex 21:1485-1497.
99. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. 2011. Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspect Med 1:a006189.
100. Sherwood CC, Subiaul F, Zawidzki TW. 2008. A natural history of the human mind: tracing evolutionary changes in brain and cognition. J Anat 212:426-454.
101. Sherwood CC, Gordon AD, Allen JS, Phillips KA, Erwin JM, Hof PR, Hopkins WD. 2011. Aging of the cerebral cortex differs between humans and chimpanzees. Proc Natl Acad Sci U S A 108:13029-13034.
102. Sherwood CC, Bauernfeind AL, Bianchi S, Raghanti MA, Hof PR. 2012. Human brain evolution writ large and small. Prog Brain Res 195:237-254.
103. Spocter MA, Hopkins WD, Barks SK, Bianchi S, Hehmeyer AE, Anderson SM, Stimpson CD, Fobbs AJ, Hof PR, Sherwood CC. 2012. Neuropil distribution in the cerebral cortex differs between humans and chimpanzees. J Comp Neurol 20:2917-2929.
104. Stephan H. 1983. Evolutionary trends in limbic structures. Neurosci Biobehav Rev 7:367-374.
105. Styren SD, Hamilton RL, Styren GC, Klunk WE. 2000. X-34, a fluorescent derivative of Congo Red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem 48:1223-1232.
106. Tekirian TL, Cole GM, Russell MJ, Yang F, Wekstein DR, Patel E, Snowdon DA, Markesbery WR, Geddes JW. 1996. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiol Aging 17:249-257.
107. Thal DR, Griffin WS, Braak H. 2008a. Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med 12:1848-1862.
108. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. 2008b. Cerebral amyloid angiopathy and its relationship to Alzheimer's disease. Acta Neuropathol 115:599-609.
109. Vehmas AK, Kawas CH, Stewart WF, Troncoso JC. 2003. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging 24:321-331.
110. Vickers JC, Riederer BM, Marugg RA, Buée-Scherrer V, Buée L, Delacourte A, Morrison JH. 1994. Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease. Neuroscience 62:1-13.
111. Vinters HV. 1987. Cerebral amyloid angiopathy. A critical review. Stroke 18:311-324.
112. Walker LC, Masters C, Beyreuther K, Price DL. 1990. Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol 80:381-387
113. Walker LC, Kitt CA, Schwam E, Buckwald B, Garcia F, Sepinwall J, Price DL. 1987. Senile plaques in aged squirrel monkeys. Neurobiol Aging 8:291-296.
114. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. 1986. A neuronal antigen in the brains of Alzheimer patients. Science 232:648-650.
115. Youmans KL, Tai LM, Kanekiyo T, Stine WB Jr, Michon SC, Nwabuisi-Heath E, Manelli AM, Fu Y, Riordan S, Eimer WA, Binder L, Bu G, Yu C, Hartley DM, LaDu MJ. 2012. Intraneuronal Abeta detection in 5xFAD mice by a new β-specific antibody. Mol Neurodegen 7:8.
116. Younkin SG. 1998. The role of Aβ42 in Alzheimer's disease. J Physiol (Paris) 92:289-292.
117. Zeng J, Konopka G, Hunt BG, Preuss TM, Geschwind D, Yi SV. 2012. Divergent whole-genome methylation maps of human and chimpanzee brains reveal epigenetic basis of human regulatory evolution. Am J Hum Genet 91:455-465.